A BILL 
To amend title XI of the Social Security Act to provide 
for the disclosure and analysis of certain health-related 
ownership information. 
Be it enacted by the Senate and House of Representa-
1
tives of the United States of America in Congress assembled, 
2
SECTION 1. SHORT TITLE. 
3
This Act may be cited as the ‘‘Healthcare Ownership 
4
Transparency Act’’. 
5
22:30 Mar 07, 2022
H6885
2 
•HR 6885 IH
SEC. 2. DISCLOSURE AND ANALYSIS OF CERTAIN HEALTH- 
1
RELATED OWNERSHIP INFORMATION. 
2
(a) IN GENERAL.—Part A of title XI of the Social 
3
Security Act (42 U.S.C. 1301 et seq.) is amended by add-
4
ing at the end the following new section: 
5
‘‘SEC. 1150C. DISCLOSURE AND ANALYSIS OF CERTAIN 
6
HEALTH-RELATED 
OWNERSHIP 
INFORMA-
7
TION. 
8
‘‘(a) REQUIRED DISCLOSURE OF CERTAIN HEALTH- 
9
RELATED
PRIVATE
EQUITY
OWNERSHIP
INFORMA-
10
TION.—The Secretary shall issue rules to require a cov-
11
ered firm to submit to the Secretary, through the Provider 
12
Enrollment, Chain, and Ownership System as part of the 
13
enrollment and revalidation of enrollment processes under 
14
title XVIII for providers of services and suppliers— 
15
‘‘(1) for a covered firm with respect to which 
16
there is a private equity fund that is a control per-
17
son of the covered fund, the information described in 
18
subsection (b); and 
19
‘‘(2) for a covered firm not described under 
20
paragraph (1), the information described in sub-
21
section (c). 
22
‘‘(b) INFORMATION SUBMITTED BY COVERED FIRMS 
23
OWNED
BY PRIVATE EQUITY.—For purposes of sub-
24
section (a) and with respect to a covered firm and each 
25
private equity fund that is a control person of the covered 
26
22:30 Mar 07, 2022
H6885
3 
•HR 6885 IH
firm, the information described in this subsection is the 
1
following information with respect to each year of the pre-
2
vious 10-year period: 
3
‘‘(1) The percentage of the equity of the private 
4
equity fund contributed by— 
5
‘‘(A) the general partners of the fund; and 
6
‘‘(B) the limited partners of the fund. 
7
‘‘(2) The level of debt of the covered firm at the 
8
end of the applicable year. 
9
‘‘(3) Information on the debt held by the pri-
10
vate equity fund, including— 
11
‘‘(A) the dollar amount of total debt; 
12
‘‘(B) the percentage of debt for which the 
13
creditor is a financial institution in the United 
14
States; 
15
‘‘(C) the percentage of debt for which the 
16
creditor is a financial institution outside of the 
17
United States; 
18
‘‘(D) the percentage of debt for which the 
19
creditor is an entity that is located in the 
20
United States and is not a financial institution; 
21
and 
22
‘‘(E) the percentage of debt for which the 
23
creditor is an entity that is located outside of 
24
22:30 Mar 07, 2022
H6885
4 
•HR 6885 IH
the United States and is not a financial institu-
1
tion. 
2
‘‘(4) The total amount of debt held by the cov-
3
ered firm that is categorized as— 
4
‘‘(A) liabilities; 
5
‘‘(B) long-term liabilities; and 
6
‘‘(C) payment in kind or zero coupon debt. 
7
‘‘(5) The average debt-to-equity ratio of— 
8
‘‘(A) each covered firm with respect to the 
9
private equity fund; and 
10
‘‘(B) the private equity fund. 
11
‘‘(6) The average debt-to-EBITDA (Earnings 
12
Before Interest, Taxes, Depreciation, and Amortiza-
13
tion) of each covered firm with respect to the private 
14
equity fund. 
15
‘‘(7) The total number of covered firms with re-
16
spect to the private equity fund that experienced a 
17
default during the applicable year, and the name of 
18
any such covered firm. 
19
‘‘(8) The total gross asset value of each covered 
20
firm with respect to the private equity fund. 
21
‘‘(9) The gross performance of the private eq-
22
uity fund during the applicable year. 
23
‘‘(10) The total dollar amount of aggregate fees 
24
and expenses collected by the private equity fund, 
25
22:30 Mar 07, 2022
H6885
5 
•HR 6885 IH
the manager of the fund, or related parties from 
1
covered firms with respect to the private equity 
2
fund, which shall— 
3
‘‘(A) be categorized by the type of fee; and 
4
‘‘(B) include a description of the purpose 
5
of the fees. 
6
‘‘(11) Any transaction, monitoring, manage-
7
ment, performance, or other fees collected by the 
8
private equity fund from the covered firm. 
9
‘‘(12) In dollars, the total amount of regulatory 
10
assets under management by the private equity 
11
fund. 
12
‘‘(13) In dollars, the total amount of net assets 
13
under management by the private equity fund. 
14
‘‘(14) With respect to the applicable year, the 
15
difference obtained by subtracting the financial 
16
gains of the private equity fund by the fees that the 
17
general partners of the fund charged to the limited 
18
partners of the fund (commonly referred to as the 
19
‘performance net of fees’). 
20
‘‘(15) Any management services agreements be-
21
tween the covered firm and the private equity fund, 
22
including a disclosure of fees paid through manage-
23
ment services agreements. 
24
22:30 Mar 07, 2022
H6885
6 
•HR 6885 IH
‘‘(16) Any other services procured by the cov-
1
ered firm from the private equity fund or any other 
2
company owned by the private equity fund. 
3
‘‘(17) Dividends paid by the covered firm to the 
4
private equity fund. 
5
‘‘(18) The names of— 
6
‘‘(A) the limited partners of the private eq-
7
uity fund; 
8
‘‘(B) the board members of the private eq-
9
uity fund; and 
10
‘‘(C) the leadership of the covered firm. 
11
‘‘(19) All political spending by the covered firm, 
12
including contributions, lobbying spending, and con-
13
tributions to groups that do not share their donor 
14
list. 
15
‘‘(20) All political spending by the private eq-
16
uity fund, an affiliate of the fund, or an investment 
17
professional at the fund, with respect to— 
18
‘‘(A) health care-related issues; or 
19
‘‘(B) members of congressional committees 
20
with oversight of health care. 
21
‘‘(21) Information on the extent to which the 
22
covered firm entered into any sale lease back trans-
23
actions with the private equity fund. 
24
22:30 Mar 07, 2022
H6885
7 
•HR 6885 IH
‘‘(22) Every asset purchased by the covered 
1
firm during the applicable year. 
2
‘‘(23) Information that is similar to the infor-
3
mation of the kind that would be required to be in-
4
cluded in a notification filed pursuant to the rules 
5
issued under subsection 7A(d)(1) of the Clayton Act 
6
(15 U.S.C. 18a(d)(1)). 
7
‘‘(24) Data related to real estate, mortgage, 
8
and lease payments. 
9
‘‘(25) Interest expenses and payments made by 
10
the private equity fund and each covered firm with 
11
respect to the private equity fund to comply with tax 
12
receivable agreements. 
13
‘‘(26) Average interest rate paid on secured and 
14
unsecured lines of credit by the private equity fund 
15
and each covered firm with respect to the private eq-
16
uity fund. 
17
‘‘(27) For the private equity fund and each cov-
18
ered firm with respect to the private equity fund, a 
19
list of— 
20
‘‘(A) all transactions with the 10 largest 
21
vendors or service providers; and 
22
‘‘(B) any new vendors or service providers. 
23
22:30 Mar 07, 2022
H6885
8 
•HR 6885 IH
‘‘(28) For the private equity fund and each cov-
1
ered firm with respect to the private equity fund, the 
2
number of payments to staffing firms. 
3
‘‘(c) INFORMATION SUBMITTED BY COVERED FIRMS 
4
NOT OWNED BY PRIVATE EQUITY.—For purposes of sub-
5
section (a) and with respect to a covered firm, the infor-
6
mation described in this subsection is the following infor-
7
mation with respect to each year of the previous 10-year 
8
period: 
9
‘‘(1) The level of debt of the covered firm at the 
10
end of the applicable year. 
11
‘‘(2) The total amount of debt held by the cov-
12
ered firm that is categorized as— 
13
‘‘(A) liabilities; 
14
‘‘(B) long-term liabilities; and 
15
‘‘(C) payment in kind or zero coupon debt. 
16
‘‘(3) The average debt-to-equity ratio of the 
17
covered firm. 
18
‘‘(4) The average debt-to-EBITDA (Earnings 
19
Before Interest, Taxes, Depreciation, and Amortiza-
20
tion) of the covered firm. 
21
‘‘(5) Whether the covered firm experienced a 
22
default during the applicable year. 
23
‘‘(6) The total gross asset value of the covered 
24
firm. 
25
22:30 Mar 07, 2022
H6885
9 
•HR 6885 IH
‘‘(7) Dividends paid by the covered firm. 
1
‘‘(8) The names of the leadership of the covered 
2
firm. 
3
‘‘(9) All political spending by the covered firm, 
4
including contributions, lobbying spending, and con-
5
tributions to groups that do not share their donor 
6
list. 
7
‘‘(10) Every asset purchased by the covered 
8
firm during the applicable year. 
9
‘‘(11) Information that is similar to the infor-
10
mation of the kind that would be required to be in-
11
cluded in a notification filed pursuant to the rules 
12
issued under subsection 7A(d)(1) of the Clayton Act 
13
(15 U.S.C. 18a(d)(1)). 
14
‘‘(12) Data related to real estate, mortgage, 
15
and lease payments. 
16
‘‘(13) Interest expenses and payments made to 
17
comply with tax receivable agreements. 
18
‘‘(14) Average interest rate paid on secured and 
19
unsecured lines of credit. 
20
‘‘(15) A list of— 
21
‘‘(A) all transactions with the 10 largest 
22
vendors or service providers; and 
23
‘‘(B) any new vendors or servicer pro-
24
viders. 
25
22:30 Mar 07, 2022
H6885
10 
•HR 6885 IH
‘‘(16) The number of payments to staffing 
1
firms. 
2
‘‘(d) REQUIREMENT TO PROVIDE INFORMATION TO 
3
A COVERED FIRM.—A private equity fund that is a control 
4
person of a covered firm shall provide the covered firm 
5
with any information required to complete a disclosure 
6
under this section. 
7
‘‘(e) GAO ANALYSIS.— 
8
‘‘(1) ANALYSIS.—Not later than 12 months 
9
after the date of implementation of this section, and 
10
every 3 years thereafter during the 12-year period 
11
beginning on the date of the enactment of this sec-
12
tion, the Comptroller General of the United States 
13
shall conduct a comparative analysis, using the in-
14
formation submitted under this section, to determine 
15
to what extent health care consolidation is taking 
16
place and how this consolidation and private equity’s 
17
involvement in health care is contributing, among 
18
other factors, to the following indicators: 
19
‘‘(A) Revenue and cost to charge ratio. 
20
‘‘(B) Payor mix and case mix index. 
21
‘‘(C) In-network versus out of network re-
22
ferrals. 
23
‘‘(D) Quality ratings for the health care fa-
24
cilities. 
25
22:30 Mar 07, 2022
H6885
11 
•HR 6885 IH
‘‘(E) Regulation compliance violations, in-
1
cluding dischargers for patients with Medicare 
2
or Medicaid coverage and total discharges per 
3
year. 
4
‘‘(F) Staffing levels and ratios. 
5
‘‘(G) Employee wages. 
6
‘‘(H) Hospital capacity, including number 
7
of beds. 
8
‘‘(2) REPORT.—After each analysis required 
9
under paragraph (1) is completed, the Comptroller 
10
General shall issue a report on all findings and con-
11
clusions made in carrying out such analysis to the 
12
Congress, the Secretary of Health and Human Serv-
13
ices, and the task force established under section 3 
14
of the Healthcare Ownership Transparency Act. 
15
‘‘(f) AUDITS.—The Secretary shall audit a random 
16
sample annually of applications submitted through the 
17
Provider Enrollment, Chain, and Ownership System as 
18
part of the enrollment and revalidation of enrollment proc-
19
esses under title XVIII to verify compliance with the re-
20
quirements of this section and accuracy of information 
21
submitted pursuant to this section. 
22
‘‘(g) DEFINITIONS.—In this section: 
23
‘‘(1) AFFILIATE.—The term ‘affiliate’ means— 
24
22:30 Mar 07, 2022
H6885
12 
•HR 6885 IH
‘‘(A) a person that directly or indirectly 
1
owns, controls, or holds with power to vote, 20 
2
percent or more of the outstanding voting secu-
3
rities of another entity, other than a person 
4
that holds such securities— 
5
‘‘(i) in a fiduciary or agency capacity 
6
without sole discretionary power to vote 
7
such securities; or 
8
‘‘(ii) solely to secure a debt, if such 
9
entity has not in fact exercised such power 
10
to vote; 
11
‘‘(B) a corporation 20 percent or more of 
12
whose outstanding voting securities are directly 
13
or indirectly owned, controlled, or held with 
14
power to vote, by another entity (referred to in 
15
this subparagraph as a ‘covered entity’), or by 
16
an entity that directly or indirectly owns, con-
17
trols, or holds with power to vote, 20 percent or 
18
more of the outstanding voting securities of the 
19
covered entity, other than an entity that holds 
20
such securities— 
21
‘‘(i) in a fiduciary or agency capacity 
22
without sole discretionary power to vote 
23
such securities; or 
24
22:30 Mar 07, 2022
H6885
13 
•HR 6885 IH
‘‘(ii) solely to secure a debt, if such 
1
entity has not in fact exercised such power 
2
to vote; 
3
‘‘(C) a person whose business is operated 
4
under a lease or operating agreement by an-
5
other entity, or person substantially all of whose 
6
property is operated under an operating agree-
7
ment with that other entity; or 
8
‘‘(D) an entity that operates the business 
9
or substantially all of the property of another 
10
entity under a lease or operating agreement. 
11
‘‘(2) CONTROL
PERSON.—The term ‘control 
12
person’— 
13
‘‘(A) means a person that directly or indi-
14
rectly owns, controls, or holds— 
15
‘‘(i) the power to vote more than 20 
16
percent of any class of voting securities of 
17
a covered firm; or 
18
‘‘(ii) any lesser percentage of any 
19
class of voting securities of a covered firm 
20
that is sufficient to give the ability to di-
21
rect the actions of the covered firm; and 
22
‘‘(B) does not include a person that— 
23
‘‘(i) holds the voting interests of a 
24
covered firm solely— 
25
22:30 Mar 07, 2022
H6885
14 
•HR 6885 IH
‘‘(I) in a fiduciary or agency ca-
1
pacity 
without 
sole 
discretionary 
2
power to vote the securities; or 
3
‘‘(II) to secure a debt, if the per-
4
son has not exercised the power to 
5
vote; or 
6
‘‘(ii)(I) is a limited partner with re-
7
spect to a person described in subpara-
8
graph (A) that is a partnership; and 
9
‘‘(II) does not participate in the direc-
10
tion of the management or policy of the 
11
covered firm. 
12
‘‘(3) CORPORATION.—The term ‘corporation’ 
13
means— 
14
‘‘(A) a joint-stock company; 
15
‘‘(B) a company or partnership association 
16
organized under a law that makes only the cap-
17
ital subscribed or callable up to a specified 
18
amount responsible for the debts of the associa-
19
tion, including a limited partnership and a lim-
20
ited liability company; 
21
‘‘(C) a trust; and 
22
‘‘(D) an association having a power or 
23
privilege that a private corporation, but not an 
24
individual or a partnership, possesses. 
25
22:30 Mar 07, 2022
H6885
15 
•HR 6885 IH
‘‘(4) COVERED FIRM.—The term ‘covered firm’ 
1
means a corporation that is— 
2
‘‘(A) a provider of services or supplier that 
3
meets all applicable requirements under title 
4
XVIII for participating in the Medicare pro-
5
gram under such title; or 
6
‘‘(B) any other person or entity who may 
7
receive reimbursements, payments, or other 
8
funds from the Centers for Medicare & Med-
9
icaid Services. 
10
‘‘(5) PRIVATE EQUITY FUND.—The term ‘pri-
11
vate equity fund’ means— 
12
‘‘(A)(i) a company or partnership that 
13
would be considered an investment company 
14
under section 3 of the Investment Company Act 
15
of 1940 (15 U.S.C. 80a–3) but for the applica-
16
tion of paragraph (1) or (7) of subsection (c) 
17
of such section 3; 
18
‘‘(ii) a venture capital fund, as defined 
19
under section 275.203(l)–1of title 17, Code of 
20
Federal Regulations; or 
21
‘‘(iii) a sovereign wealth fund; and 
22
‘‘(B) directly, or through an affiliate, acts 
23
as a control person.’’. 
24
22:30 Mar 07, 2022
H6885
16 
•HR 6885 IH
(b) EXCLUSION FROM PARTICIPATION UNDER MEDI-
1
CARE.—Section 1128(b) of the Social Security Act (42 
2
U.S.C. 1320a–7(b)) is amended by adding at the end the 
3
following new paragraph: 
4
‘‘(18) FAILURE TO DISCLOSE CERTAIN PECOS 
5
INFORMATION.—With respect to exclusion pursuant 
6
to this subsection from participation in the Medicare 
7
program under title XVIII, any entity to which sec-
8
tion 1150C applies that did not fully and accurately 
9
make any disclosure required by such section.’’. 
10
SEC. 3. TASK FORCE TO ANALYZE AND PROVIDE REC-
11
OMMENDATIONS ON THE ROLE OF PRIVATE 
12
EQUITY AND CONSOLIDATION IN HEALTH 
13
CARE. 
14
(a) ESTABLISHMENT.—The Secretary of Health and 
15
Human Services shall establish and operate a task force 
16
to address and limit the role of private equity and consoli-
17
dation in healthcare (the ‘‘Task Force’’). 
18
(b) COMPOSITION.— 
19
(1) CHAIR.—The Secretary of Health and 
20
Human Services shall chair the Task Force. 
21
(2) MEMBERS.—The Secretary shall appoint 
22
the members of the Task Force from among the fol-
23
lowing: 
24
22:30 Mar 07, 2022
H6885
17 
•HR 6885 IH
(A) Academic experts and researchers with 
1
expertise on— 
2
(i) the role of private equity in 
3
healthcare; and 
4
(ii) the impact of mergers and acquisi-
5
tions in healthcare on costs and patients. 
6
(B) Representatives from organizations fo-
7
cused on consumer protection, antitrust, patient 
8
advocacy, and worker advocacy. 
9
(C) Hospital and health care staff. 
10
(D) Patients. 
11
(3) ADVISORY MEMBERS.—In addition to the 
12
members described under paragraph (2), the chair-
13
man of the Federal Trade Commission and the At-
14
torney General shall serve as advisory members of 
15
the Task Force. 
16
(4) MEMBER
APPOINTMENT.—Not later than 
17
60 days after the receipt of the first report issued 
18
by the Comptroller General of the United States 
19
under section 1150C of the Social Security Act, the 
20
Secretary of Health and Human Services shall ap-
21
point the members of the Task Force— 
22
(A) in accordance with paragraph (2); and 
23
(B) using a competitive application proc-
24
ess. 
25
22:30 Mar 07, 2022
H6885
18 
•HR 6885 IH
(c) RECOMMENDATIONS.—The Task Force shall, 
1
based on the results of such study and the report issued 
2
by the Comptroller General of the United States under 
3
section 1150C of the Social Security Act identify best 
4
practices (and for purposes of subsection (d) develop rec-
5
ommendations) for limiting the role of private equity in 
6
health care, taking into account the implications on health 
7
outcomes and staff working conditions. 
8
(d) REPORT.—Not later than 6 months after the date 
9
of the first report issued by the Comptroller General of 
10
the United States under section 1150C of the Social Secu-
11
rity Act, and every 6 months thereafter, the Secretary of 
12
Health and Human Services shall submit to Congress a 
13
report— 
14
(1) on the recommendations developed sub-
15
section (c); and 
16
(2) that includes regulatory and legislative rec-
17
ommendations to address any adverse effects of 
18
health care consolidation and private equity’s in-
19
volvement in health care. 
20
(e) MORATORIUM.— 
21
(1) IN GENERAL.—The Secretary of Health and 
22
Human Services may prohibit a private equity fund 
23
from purchasing voting securities of a covered firm, 
24
and may prohibit any merger or acquisition that 
25
22:30 Mar 07, 2022
H6885
19 
•HR 6885 IH
would result in a private equity fund gaining control 
1
of voting securities of a covered firm, until the date 
2
on which the Secretary determines that the Task 
3
Force has had sufficient time to study and identify 
4
whether abuses are taking place in specific health 
5
care sectors or by health care entities related to 
6
price gauging, understaffing, regulation compliance 
7
violations, or such other metrics as the Secretary 
8
may determinate appropriate. 
9
(2) DEFINITIONS.—In this subsection: 
10
(A) COVERED FIRM.—The term ‘‘covered 
11
firm’’ has the meaning given that term under 
12
section 1150C(g) of the Social Security Act. 
13
(B) PRIVATE
EQUITY
FUND.—The term 
14
‘‘private equity fund’’ means— 
15
(i) a company or partnership that 
16
would be considered an investment com-
17
pany under section 3 of the Investment 
18
Company Act of 1940 (15 U.S.C. 80a–3) 
19
but for the application of paragraph (1) or 
20
(7) of subsection (c) of such section 3; 
21
(ii) a venture capital fund, as defined 
22
under section 275.203(l)–1of title 17, Code 
23
of Federal Regulations; and 
24
22:30 Mar 07, 2022
H6885
20 
•HR 6885 IH
(iii) a sovereign wealth fund. 
1
Æ 
22:30 Mar 07, 2022
H6885
